Given the critical relevance of mitophagy and mitochondrial dysfunction in PD and particularly in PINK1-related PD, restoring normal mitophagy by targeting the PINK1/Parkin pathway is an emerging promising therapeutic approach for the disease. This evidence concerns the gene PRKN and Parkinson disease.